Literature DB >> 25339153

Activation of TRPV1 attenuates high salt-induced cardiac hypertrophy through improvement of mitochondrial function.

Hongmei Lang1, Qiang Li1, Hao Yu1, Peng Li2, Zongshi Lu1, Shiqiang Xiong1, Tao Yang1, Yu Zhao1, Xiaohu Huang1, Peng Gao1, Hexuan Zhang1, Qianhui Shang2, Daoyan Liu1, Zhiming Zhu1.   

Abstract

BACKGROUND AND
PURPOSE: High-salt diet induces cardiac remodelling and leads to heart failure, which is closely related to cardiac mitochondrial dysfunction. Transient receptor potential (TRP) channels are implicated in the pathogenesis of cardiac dysfunction. We investigated whether activation of TRP vanilloid (subtype 1) (TRPV1) channels by dietary capsaicin can, by ameliorating cardiac mitochondrial dysfunction, prevent high-salt diet-induced cardiac hypertrophy. EXPERIMENTAL APPROACH: Male wild-type (WT) and TRPV1(-/-) mice were fed a normal or high-salt diet with or without capsaicin for 6 months. Their cardiac parameters and endurance capacity were assessed. Mitochondrial respiration and oxygen consumption were measured using high-resolution respirometry. The expression levels of TRPV1, sirtuin 3 and NDUFA9 were detected in cardiac cells and tissues. KEY
RESULTS: Chronic high-salt diet caused cardiac hypertrophy and reduced physical activity in mice; both effects were ameliorated by capsaicin intake in WT but not in TRPV1(-/-) mice. TRPV1 knockout or high-salt diet significantly jeopardized the proficiency of mitochondrial Complex I oxidative phosphorylation (OXPHOS) and reduced Complex I enzyme activity. Chronic dietary capsaicin increased cardiac mitochondrial sirtuin 3 expression, the proficiency of Complex I OXPHOS, ATP production and Complex I enzyme activity in a TRPV1-dependent manner. CONCLUSIONS AND IMPLICATIONS: TRPV1 activation by dietary capsaicin can antagonize high-salt diet-mediated cardiac lesions by ameliorating its deleterious effect on the proficiency of Complex I OXPHOS. TRPV1-mediated amendment of mitochondrial dysfunction may represent a novel target for management of early cardiac dysfunction.
© 2014 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25339153      PMCID: PMC4667858          DOI: 10.1111/bph.12987

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  47 in total

1.  High salt intake: a cause of blood pressure-independent left ventricular hypertrophy?

Authors:  Michel Burnier; Olivier Phan; Qing Wang
Journal:  Nephrol Dial Transplant       Date:  2007-06-07       Impact factor: 5.992

2.  Activation of TRPV1 by dietary capsaicin improves endothelium-dependent vasorelaxation and prevents hypertension.

Authors:  Dachun Yang; Zhidan Luo; Shuangtao Ma; Wing Tak Wong; Liqun Ma; Jian Zhong; Hongbo He; Zhigang Zhao; Tingbing Cao; Zhencheng Yan; Daoyan Liu; William J Arendshorst; Yu Huang; Martin Tepel; Zhiming Zhu
Journal:  Cell Metab       Date:  2010-08-04       Impact factor: 27.287

Review 3.  TRPC channels as effectors of cardiac hypertrophy.

Authors:  Petra Eder; Jeffery D Molkentin
Journal:  Circ Res       Date:  2011-01-21       Impact factor: 17.367

Review 4.  Oxidative stress and redox signalling in cardiac hypertrophy and heart failure.

Authors:  Mike Seddon; Yee H Looi; Ajay M Shah
Journal:  Heart       Date:  2006-05-02       Impact factor: 5.994

5.  Amelioration of cardiac remodeling in congestive heart failure by beta-adrenoceptor blockade is associated with depression in sympathetic activity.

Authors:  Jarmila Machackova; Santosh K Sanganalmath; Judit Barta; Ken S Dhalla; Naranjan S Dhalla
Journal:  Cardiovasc Toxicol       Date:  2010-03       Impact factor: 3.231

Review 6.  Alterations in mitochondrial function in cardiac hypertrophy and heart failure.

Authors:  Moritz Osterholt; T Dung Nguyen; Michael Schwarzer; Torsten Doenst
Journal:  Heart Fail Rev       Date:  2013-09       Impact factor: 4.214

7.  A mitochondrial protein compendium elucidates complex I disease biology.

Authors:  David J Pagliarini; Sarah E Calvo; Betty Chang; Sunil A Sheth; Scott B Vafai; Shao-En Ong; Geoffrey A Walford; Canny Sugiana; Avihu Boneh; William K Chen; David E Hill; Marc Vidal; James G Evans; David R Thorburn; Steven A Carr; Vamsi K Mootha
Journal:  Cell       Date:  2008-07-11       Impact factor: 41.582

8.  The Concise Guide to PHARMACOLOGY 2013/14: enzymes.

Authors:  Stephen P H Alexander; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Michael Spedding; John A Peters; Anthony J Harmar
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

9.  The Concise Guide to PHARMACOLOGY 2013/14: ion channels.

Authors:  Stephen P H Alexander; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; William A Catterall; Michael Spedding; John A Peters; Anthony J Harmar
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

10.  The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledgebase of drug targets and their ligands.

Authors:  Adam J Pawson; Joanna L Sharman; Helen E Benson; Elena Faccenda; Stephen P H Alexander; O Peter Buneman; Anthony P Davenport; John C McGrath; John A Peters; Christopher Southan; Michael Spedding; Wenyuan Yu; Anthony J Harmar
Journal:  Nucleic Acids Res       Date:  2013-11-14       Impact factor: 16.971

View more
  23 in total

1.  Expression of transient receptor potential vanilloid genes and proteins in diabetic rat heart.

Authors:  Xiaoli Jia; Tao Yu; Chao Xiao; Deqiao Sheng; Mengcheng Yang; Quanyi Cheng; Jing Wu; Ting Lian; Yun Zhao; Shizhong Zhang
Journal:  Mol Biol Rep       Date:  2021-02-01       Impact factor: 2.316

Review 2.  The endocannabinoid system in cardiovascular function: novel insights and clinical implications.

Authors:  Salvador Sierra; Natasha Luquin; Judith Navarro-Otano
Journal:  Clin Auton Res       Date:  2017-12-08       Impact factor: 4.435

Review 3.  Channelling the Force to Reprogram the Matrix: Mechanosensitive Ion Channels in Cardiac Fibroblasts.

Authors:  Leander Stewart; Neil A Turner
Journal:  Cells       Date:  2021-04-23       Impact factor: 6.600

Review 4.  Transient receptor potential channels in cardiac health and disease.

Authors:  Thomas Hof; Sébastien Chaigne; Alice Récalde; Laurent Sallé; Fabien Brette; Romain Guinamard
Journal:  Nat Rev Cardiol       Date:  2019-06       Impact factor: 32.419

5.  Chinese innovation in cardiovascular drug discovery.

Authors:  Xin Wang; Yong Ji; Baofeng Yang
Journal:  Br J Pharmacol       Date:  2015-12       Impact factor: 8.739

Review 6.  Does Transient Receptor Potential Vanilloid Type 1 Alleviate or Aggravate Pathological Myocardial Hypertrophy?

Authors:  Qiqi Yan; Jun Tang; Xin Zhang; Liuyang Wu; Yunyi Xu; Lihong Wang
Journal:  Front Pharmacol       Date:  2021-05-10       Impact factor: 5.810

7.  Ultra-low doses of the transient receptor potential vanilloid 1 agonist, resiniferatoxin, prevents vomiting evoked by diverse emetogens in the least shrew (Cryptotis parva).

Authors:  Nissar A Darmani; Denise A Henry; Weixia Zhong; Seetha Chebolu
Journal:  Behav Pharmacol       Date:  2020-02       Impact factor: 2.277

Review 8.  Perspectives of TRPV1 Function on the Neurogenesis and Neural Plasticity.

Authors:  R Ramírez-Barrantes; C Cordova; H Poblete; P Muñoz; I Marchant; F Wianny; P Olivero
Journal:  Neural Plast       Date:  2016-01-05       Impact factor: 3.599

9.  TRPA1 is functionally co-expressed with TRPV1 in cardiac muscle: Co-localization at z-discs, costameres and intercalated discs.

Authors:  Spencer R Andrei; Pritam Sinharoy; Ian N Bratz; Derek S Damron
Journal:  Channels (Austin)       Date:  2016-05-04       Impact factor: 2.581

Review 10.  Dietary Capsaicin Protects Cardiometabolic Organs from Dysfunction.

Authors:  Fang Sun; Shiqiang Xiong; Zhiming Zhu
Journal:  Nutrients       Date:  2016-04-25       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.